Speaker illustration

Doctor Zsofia Nagy

Gottsegen National Cardiovascular Center, Budapest (Hungary)

Member of:

European Heart Rythm Association

The challenge of transseptal access for catheter ablation of left-sided arrhythmia substrate in infants and small children under 6 years of age

Event: EHRA 2024

Topic: Catheter Ablation of Arrhythmias

Session: Congenital

Thumbnail

Clinical outcomes and procedural characteristics of ventricular tachycardia ablation in patients with or without electrical storm

Event: EHRA 2023

Topic: Ablation of Ventricular Arrhythmias

Session: ePoster session 35

Thumbnail

Pulmonary vein reconnection observed with multielectrode mapping late after second-generation cryoballoon or contact force-sensing radiofrequency catheter ablation for atrial fibrillation

Event: EHRA 2019

Topic: Rhythm Control, Catheter Ablation

Session: Atrial Fibrillation - Treatment

Thumbnail

One year incidence of iatrogenic atrial septal defect after radiofrequency or cryoballoon ablation for paroxysmal atrial fibrillation

Event: EHRA 2018

Topic: Rhythm Control, Catheter Ablation

Session: Atrial fibrillation complications

Thumbnail

Four-year follow-up after contact force sensing radiofrequency catheter and second-generation cryoballoon ablation for paroxysmal atrial fibrillation

Event: EHRA 2018

Topic: Catheter Ablation of Arrhythmias

Session: Atrial fibrillation ablation - Mechanisms and outcomes

Thumbnail

Myocardial injury biomarkers and outcomes after pulmonary vein isolation using contact force sensing radiofrequency catheter or advanced cryoballoon

Event: EHRA 2018

Topic: Rhythm Control, Catheter Ablation

Session: Atrial fibrillation ablation - Mechanisms and outcomes

Thumbnail

Persistent iatrogenic atrial septal defect after radiofrequency or cryoballoon ablation for paroxysmal atrial fibrillation

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Catheter ablation (Atrial Fibrillation)

Session: Atrial Fibrillation - Catheter ablation

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb